Health Encyclopedia

 

Document Search by P00133



Breast Cancer Prevention Trial (BCPT) Ensayo para la Prevención del Cáncer del Seno

Breast Cancer Prevention Trial (BCPT)

The BCPT, part of the National Surgical Adjuvant Breast and Bowel Project (NSABP), began in April 1992 to determine whether the nonsteroidal, anti-estrogen drug tamoxifen could reduce the incidence of breast cancer in women who were at high risk for development of the disease. Only women who were at increased risk for developing breast cancer participated in the study. They were chosen based on their breast cancer risk as determined by a computer calculation that included specific factors.

By September 1997, more than 13,000 women had participated in the study. Data showed the results of tamoxifen treatment to be highly significant with a 49% reduction in the number of invasive breast cancers seen across all age groups. These results were confirmed in the final report issued in 2005.

The data were then turned over to the Endpoint Review, Safety Monitoring, and Advisory Committee for review of the toxicity, adverse side effects, and effectiveness of tamoxifen. This independent committee (whose members are not affiliated with either the NSABP or BCPT) concluded that the overall benefits of treatment with tamoxifen outweighed the overall risks.

Tamoxifen is one of the most widely prescribed cancer drugs in the world, and has been the focus of research on its actions, benefits, and risks for more than 30 years. Still, tamoxifen therapy may not be appropriate for all women who are at increased risk for breast cancer.

Before tamoxifen is prescribed, a woman and her doctor should take into consideration her age, personal history, and family history. She and her doctor should also weigh the benefits and risks of tamoxifen.

The use of tamoxifen is reportedly associated with some infrequent, but potentially life-threatening side effects. Endometrial cancer, pulmonary embolism, and deep vein thrombosis are conditions that may be caused or adversely affected by tamoxifen. Other common side effects include fatigue, which may go away after taking the drug for a few weeks, and hot flashes.

 
Related Items
Wellness Library
  Solving the Breast Cancer Puzzle
  Reducing Your Risk for Breast Cancer
  Certain Factors Help Predict Invasive Breast Cancer
  Hope on the Horizon for Breast Cancer
  Stay Healthy After Breast Cancer
Content Type 167
  BRCA
  CA 15-3
  CA 27-29
  Immunohistochemical Test for Estrogen and Progesterone Receptors
Cancer Source
  Sex and Cancer: Questions for Your Doctor
  Breast Cancer—Understanding Genetic Testing
  The Soy and Breast Cancer Controversy: Cause for Concern?
  The 'Chemobrain' Phenomenon in Breast Cancer
  MRIs for Breast Cancer Screening—Who Needs Them?
  Hormonal Therapy: Managing Side Effects in Women
  If You Are Having Hormonal Therapy
  What Is Breast Cancer?
  What to Know About Your Treatment Choices for Breast Cancer
  Ductal Carcinoma
  Statistics About Breast Cancer
  Can I Get Checked for Breast Cancer Before I Have Symptoms?
  What Can I Do if I Am at Risk for Breast Cancer?
  What Are the Symptoms of Breast Cancer?
  How Does My Doctor Know I Have Breast Cancer?
  Tests That Help Evaluate the Traits of Your Breast Cancer
  Understanding Your Grade and Stage of Breast Cancer
  What to Know About Surgery for Breast Cancer
  Breast Cancer: What Happens After Reconstructive Surgery
  Goal of Chemotherapy for Breast Cancer
  Do What You Can to Ease Side Effects of Treatment and Symptoms for Breast Cancer
  Finding Out You Have Breast Cancer
  What to Know About Combination Therapy for Breast Cancer
  How You Get Radiation for Breast Cancer
  What You Need to Know About Hormone Therapy for Breast Cancer
  Tips for Feeling Your Best During Treatment for Breast Cancer
  Taking Care of Your Incision After Breast Surgery
  How Your Doctor Uses Biopsies to Make Your Diagnosis of Breast Cancer
  Understanding Your Type of Breast Cancer
  What to Know About Inflammatory Breast Cancer (IBC)
  Can I Survive Breast Cancer? What Is My Prognosis?
  Am I at Risk for Breast Cancer?
  Myths About What Causes Breast Cancer
  Questions to Ask About Treatment for Breast Cancer
  What to Expect After Surgery for Breast Cancer
  What Happens During Radiation Therapy for Breast Cancer
  What to Expect After Radiation Treatment for Breast Cancer
  What Happens During Chemotherapy for Breast Cancer
  Making the Decision to Have Hormone Therapy for Breast Cancer
  What Happens During Hormone Therapy for Breast Cancer
  Ovarian Ablation as Hormone Therapy for Breast Cancer
  What to Expect After Taking Hormone Therapy Drugs for Breast Cancer
  What to Know About Targeted Therapy for Breast Cancer
  What Happens During Targeted Therapy for Breast Cancer
  Making the Decision to Have Breast Reconstruction After a Mastectomy for Breast Cancer
  When Breast Cancer Spreads to the Bones
  Exercising After Breast Cancer: Moving Toward Health
  Aromatase Inhibitors for Breast Cancer
Cancer FAQs
  Breast Cancer FAQ
NCI Patient Summary
  Breast Cancer Treatment and Pregnancy (PDQ®)
Quizzes
  Breast Cancer Quiz
MRAs
  Breast Cancer Risk Assessment
Adult Diseases and Conditions
  Chemotherapy for Breast Cancer Treatment
  About Clinical Trials: Information from the National Cancer Institute
  How Is Breast Cancer Diagnosed?
  General Information About Breast Cancer
  Other Treatments for Breast Cancer
  National Surgical Adjuvant Breast and Bowel Project (NSABP)
  Post-Mastectomy
  Radiation Therapy for Breast Cancer Treatment
  Risk Factors for Breast Cancer
  Signs and Symptoms of Breast Cancer
  Stages of Breast Cancer
  Study of Tamoxifen and Raloxifene (STAR)
  Breast Cancer Statistics
  About Taxol
  Breast Health: Three-Step Plan for Preventive Care
  Treatments for Breast Cancer
  Hereditary Breast Ovarian Cancer Syndrome (BRCA1/BRCA2)
  Genetics of Breast Cancer
  Breast Cancer Overview
Newsletters
  Should You Consider Preventive Drugs for Breast Cancer?
  Should You Be Tested for the Breast Cancer Gene?
Test and Procedures
  Breast Biopsy